Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

被引:584
作者
Bajou, K
Noël, A
Gerard, RD
Masson, V
Brunner, N
Holst-Hansen, C
Skobe, M
Fusenig, NE
Carmeliet, P
Collen, D
Foidart, JM
机构
[1] Univ Liege, Lab Tumor & Dev Biol, B-4000 Liege, Belgium
[2] Flanders Interuniv Inst Biotechnol, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium
[3] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark
[4] German Canc Res Ctr, Div Carcinogenesis & Differentiat, D-69120 Heidelberg, Germany
关键词
D O I
10.1038/nm0898-923
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acquisition of invasive/metastatic potential through protease expression is an essential event in tumor progression. High levels of components of the plasminogen activation system, including urokinase, but paradoxically also its inhibitor, plasminogen activator inhibitor 1 (PAI1), have been correlated with a poor prognosis for some cancers. We report here that deficient PAI1 expression in host mice prevented local invasion and tumor vascularization of transplanted malignant keratinocytes. When this PAI1 deficiency was circumvented by intravenous injection of a replication-defective adenoviral vector expressing human PAI1, invasion and associated angiogenesis were restored. This experimental evidence demonstrates that host-produced PAI is essential for cancer cell invasion and angiogenesis.
引用
收藏
页码:923 / 928
页数:6
相关论文
共 43 条
[31]  
NAKARDA H, 1994, CANCER RES, V54, P2900
[32]  
OSSOWSKI L, 1991, CANCER RES, V51, P274
[33]  
PEDERSEN H, 1994, CANCER RES, V54, P4671
[34]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 IS INDUCED IN MIGRATING ENDOTHELIAL-CELLS [J].
PEPPER, MS ;
SAPPINO, AP ;
MONTESANO, R ;
ORCI, L ;
VASSALLI, JD .
JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 153 (01) :129-139
[35]   THE C-MYC-REGULATED GENE-MR1 ENCODES PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
PRENDERGAST, GC ;
DIAMOND, LE ;
DAHL, D ;
COLE, MD .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (03) :1265-1269
[36]  
PYKE C, 1991, CANCER RES, V51, P4067
[37]   DIFFERENTIAL PROTEASE EXPRESSION BY CUTANEOUS SQUAMOUS AND BASAL-CELL CARCINOMAS [J].
SAPPINO, AP ;
BELIN, D ;
HUARTE, J ;
HIRSCHELSCHOLZ, S ;
SAURAT, JH ;
VASSALLI, JD .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (04) :1073-1079
[38]   PLASMINOGEN ACTIVATORS AUGMENT ENDOTHELIAL-CELL ORGANIZATION IN-VITRO BY 2 DISTINCT PATHWAYS [J].
SCHNAPER, HW ;
BARNATHAN, ES ;
MAZAR, A ;
MAHESHWARI, S ;
ELLIS, S ;
CORTEZ, SL ;
BARICOS, WH ;
KLEINMAN, HK .
JOURNAL OF CELLULAR PHYSIOLOGY, 1995, 165 (01) :107-118
[39]   INACTIVE UROKINASE AND INCREASED LEVELS OF ITS INHIBITOR TYPE-1 IN COLORECTAL-CANCER LIVER METASTASIS [J].
SIER, CFM ;
VLOEDGRAVEN, HJM ;
GANESH, S ;
GRIFFIOEN, G ;
QUAX, PHA ;
VERHEIJEN, JH ;
DOOIJEWAARD, G ;
WELVAART, K ;
VANDEVELDE, CJH ;
LAMERS, CBHW ;
VERSPAGET, HW .
GASTROENTEROLOGY, 1994, 107 (05) :1449-1456
[40]   Halting angiogenesis suppresses carcinoma cell invasion [J].
Skobe, M ;
Rockwell, P ;
Goldstein, N ;
Vosseler, S ;
Fusenig, NE .
NATURE MEDICINE, 1997, 3 (11) :1222-1227